Logo image of UROV

Urovant Sciences Ltd (UROV) Stock News

NASDAQ:UROV - Nasdaq -

16.24  +0.01 (+0.06%)

After market: 16.23 -0.01 (-0.06%)

UROV Latest News, Press Relases and Analysis

News Image
4 years ago - Benzinga

The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) AngioDynamics, Inc. (...

Mentions: ALPN ADCT SLRX LEGN ...

News Image
4 years ago - Benzinga

Stocks That Hit 52-Week Highs On Wednesday

  Wednesday morning saw 162 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to set a new 52-week high was Bank of America (NYSE:...

Mentions: PM TW NSIT VEL ...

News Image
4 years ago - Lifshitz Law Firm, P.C.

Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, WORK, and UROV

NEW YORK, NY / ACCESSWIRE / January 3, 2021 / Lifshitz Law Firm, P.C.: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management. If you are a CBMG investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua

Mentions: CBMG CBLI WORK